Literature DB >> 2668763

The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents.

A P Rocchini1, J Key, D Bondie, R Chico, C Moorehead, V Katch, M Martin.   

Abstract

To clarify the role of sodium intake in the regulation of blood pressure in obese subjects, we measured blood pressure in 60 obese and 18 nonobese adolescents after successive two-week periods of a high-salt diet (greater than 250 mmol of sodium per day) and a low-salt diet (less than 30 mmol per day). When they were changed from a high-salt to a low-salt diet, the obese group had a significantly larger mean change (+/- SE) in mean arterial pressure (-12 +/- 1 mm Hg) than did the nonobese group (+1 +/- 2 mm Hg; P less than 0.001). The variables that best predicted the degree of sodium sensitivity were the fasting plasma insulin level, the plasma aldosterone level while the low-salt diet was being given, the plasma norepinephrine level while the high-salt diet was being given, and the percentage of body weight made up by fat. Fifty-one of the obese adolescents were also studied before and after a 20-week weight-loss program. After the weight-loss program, the 36 subjects who lost more than 1 kg of body weight had a reduced sensitivity of blood pressure to sodium (difference from value during high-salt diet to that during low-salt diet, -1 +/- 1 mm Hg). The blood pressure of the remaining 15 adolescents was still sensitive to sodium intake (-11 +/- 3 mm Hg). These results support the hypothesis that the blood pressure of obese adolescents is sensitive to dietary sodium intake and that this sensitivity may be due to the combined effects of the hyperinsulinemia, hyperaldosteronism, and increased activity of the sympathetic nervous system that are characteristic of obesity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668763     DOI: 10.1056/NEJM198908313210905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  117 in total

Review 1.  The medical risks of obesity.

Authors:  F Xavier Pi-Sunyer
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

Review 2.  Sodium sensitivity, not level of salt intake, predicts salt effects.

Authors:  A G Logan
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

Review 3.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 4.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

5.  Sex, Obesity, and Blood Pressure Among African American Adolescents: The Jackson Heart KIDS Pilot Study.

Authors:  Marino A Bruce; Bettina M Beech; Keith C Norris; Derek M Griffith; Mario Sims; Roland J Thorpe
Journal:  Am J Hypertens       Date:  2017-09-01       Impact factor: 2.689

Review 6.  Proximal tubular function and salt sensitivity.

Authors:  Michel Burnier; Murielle Bochud; Marc Maillard
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

7.  The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity.

Authors:  Fabrice M A C Martens; Frank L J Visseren
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 4.810

8.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

Review 9.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 10.  Salt sensitivity and hypertension.

Authors:  Olga Balafa; Rigas G Kalaitzidis
Journal:  J Hum Hypertens       Date:  2020-08-29       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.